REMEDISC Trademark

Trademark Overview

On Friday, May 17, 2019, a trademark application was filed for REMEDISC with the United States Patent and Trademark Office. The USPTO has given the REMEDISC trademark a serial number of 88436119. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 3, 2023. This trademark is owned by Spine Biopharma, LLC. The REMEDISC trademark is filed in the Chemical Products category with the following description:

Biomedical compounds, namely, amino acids for medical purposes administered for medical therapies; amino acids for medical purposes administered by injection for treatment of spinal diseases or disorders; 7-amino acid peptide chain, namely, amino acids for medical purposes administered by intradiscal injection for the treatment of lumbar degenerative disc disease
remedisc

General Information

Serial Number88436119
Word MarkREMEDISC
Filing DateFriday, May 17, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2020

Trademark Statements

Pseudo MarkREME DISC
Goods and ServicesBiomedical compounds, namely, amino acids for medical purposes administered for medical therapies; amino acids for medical purposes administered by injection for treatment of spinal diseases or disorders; 7-amino acid peptide chain, namely, amino acids for medical purposes administered by intradiscal injection for the treatment of lumbar degenerative disc disease

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, June 4, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSpine Biopharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10022
Party NameSpine Biopharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10022

Trademark Events

Event DateEvent Description
Monday, April 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 1, 2023ASSIGNED TO EXAMINER
Saturday, September 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 16, 2022SOU EXTENSION 5 GRANTED
Tuesday, September 6, 2022SOU EXTENSION 5 FILED
Friday, September 16, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 6, 2022TEAS EXTENSION RECEIVED
Saturday, March 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 3, 2022SOU EXTENSION 4 GRANTED
Thursday, March 3, 2022SOU EXTENSION 4 FILED
Thursday, March 3, 2022TEAS EXTENSION RECEIVED
Thursday, August 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 24, 2021SOU EXTENSION 3 GRANTED
Tuesday, August 24, 2021SOU EXTENSION 3 FILED
Tuesday, August 24, 2021TEAS EXTENSION RECEIVED
Friday, March 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 3, 2021SOU EXTENSION 2 GRANTED
Wednesday, March 3, 2021SOU EXTENSION 2 FILED
Wednesday, March 3, 2021TEAS EXTENSION RECEIVED
Saturday, September 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 3, 2020SOU EXTENSION 1 GRANTED
Thursday, September 3, 2020SOU EXTENSION 1 FILED
Thursday, September 3, 2020TEAS EXTENSION RECEIVED
Thursday, September 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 3, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 3, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, September 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 3, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 26, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 26, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 12, 2019NON-FINAL ACTION E-MAILED
Monday, August 12, 2019NON-FINAL ACTION WRITTEN
Monday, August 5, 2019ASSIGNED TO EXAMINER
Tuesday, June 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 21, 2019NEW APPLICATION ENTERED

Related Keywords

remedisc amino medical acids administered purposes injection treatment namely intradiscal chain